Study of Idursulfase-beta (GC1111) in Hunter Syndrome

Clinical trial NCT02663024 · UNKNOWN

Trial details

NCT number: NCT02663024
Sponsor: Green Cross Corporation
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Mucopolysaccharidosis II

Start date: 2016-12-01
Primary completion: 2019-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.